Xyrem committee meeting rescheduled

Orphan Medical (ORPH) said that the FDA's Peripheral and Central Nervous System Drugs Advisory Committee rescheduled a meeting for ORPH's Xyrem sodium oxybate solution for June 6. The meeting previous...